布地奈德雾化吸入辅助治疗小儿肺炎支原体感染

Therapy on Mycoplasma Pneumoniae Infection with Budesonide Inhalation Adjuvant

目的探讨布地奈德雾化吸入辅助治疗小儿肺炎支原体感染的临床疗效。方法将我院收治的160例支原体肺炎患儿随机分为两组,每组各80例,对照组采取常规治疗,观察组在常规治疗基础上辅助布地奈德雾化吸入,比较两组患儿的临床疗效。结果观察组患儿发热、咳嗽、喘息、肺部罗鸣音消失时间分别为(2.76±0.75)d、(5.15±1.08)d、(3.21±0.83)d、(4.87±1.13)d,均明显短于对照组,两组比较差异显著(P<0.01);观察组住院时间为(9.15±2.25)d,对照组为(14.34±2.68)d,观察组明显短于对照组,两组比较差异显著(P<0.01);观察组治疗总有效率为96.25%,对照组为82.50%,观察组明显高于对照组,两组比较差异显著(P<0.01)。结论布地奈德雾化吸入辅助治疗小儿肺炎支原体感染疗效显著,值得临床应用。

Objective To explore the efficacy of therapy on mycoplasma pneumoniae infection with budesonide inhalation adju- vant. Methods 160 cases of mycoplasma pneumonia admitted to the hospital were randomly divided into two groups, with 80 cases in each group. Cases in the control group were given conventional treatment on the basis of conventional treatment, and cases in the observation group were given auxiliary budesonide inhalation. The clinical efficacy of two groups of children was compared. Results Fever, cough, wheezing, pulmonary tales of the children of the observation group disappear time were （2.76 ＋ 0.75）d, （5.15 _＋ 1.08）d, （3.21 ＋ 0. 83）d, （4. 87 ＋ 1.13）d, and were significantly shorter than the control group, with significant difference between the two groups （P 〈 O. 01 ） ; The hospitalization time of the observation group was （ 9. 15 ~ 2. 25 ） d, and the control group was （ 14. 34 ＋_ 2.68 ） d. The observa- tion group was significantly shorter than the control group, with significant difference between the two groups （P 〈 0.01 ） ; The total effective rate of the observation group was 96. 25%, and the control group was 82. 50%. The observation group was significantly higher the control group, and the difference was significant （P 〈 O. 01 ）. Conclusion Therapy on mycoplasma pneumoniae infection with budesonide inhala- tion adjuvant has significant effect, and is worthy of clinical application.